!

ΟΛΑ ΤΑ ΝΕΑ ΓΙΑ ΤΟΝ ΚΟΡΩΝΟΪΟ

MC MEDIA NETWORK

January 28, 2021 Thursday 01:04:31

Εγγραφή στο
Newsletter

!

ΟΛΑ ΤΑ ΝΕΑ ΓΙΑ ΤΟΝ ΚΟΡΩΝΟΪΟ

Moderna’s

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study

First interim analysis included 95 participants with confirmed cases of COVID-19. Phase 3 study met statistical criteria with a vaccine efficacy of 94.5% (p...

UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna’s mRNA Vaccine Against COVID-19 (mRNA-1273)

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,...